Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Analytical Biochemistry|September 24, 2018
Spectroscopic methods for assessing the molecular origins of macroscopic solution properties of highly concentrated liquid protein solutionsJacob Blaffert, Haleh Hashemi Haeri, Michaela Blech, et al.
International Journal of Pharmaceutics|May 22, 2021
Investigating photodegradation of antibodies governed by the light dosageWolfgang Kaiser, Torsten Schultz-Fademrecht, Michaela Blech, et al.
Pharmaceutics|November 24, 2020
Particle Detection and Characterization for Biopharmaceutical Applications: Current Principles of Established and Alternative TechniquesJulia Gross-Rother, Michaela Blech, Eduard Preis, et al.
European Biophysics Journal : EBJ|May 22, 2025
Competitive adsorption of a monoclonal antibody and amphiphilic polymers to the air-water interfaceElise J Hingst, Michaela Blech, Dariush Hinderberger, et al.
Pharmaceutical Research|December 14, 2021
Expanding the toolbox for predictive parameters describing antibody stability considering thermodynamic and kinetic determinantsMichaela Blech, Richard Melien, Nuska Tschammer, et al.
Journal of Chemical Information and Modeling|March 25, 2025
Optimized Protein-Excipient Interactions in the Martini 3 Force FieldTobias M Prass, Kresten Lindorff-Larsen, Patrick Garidel, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|July 11, 2017
High-concentration protein formulations: How high is high?Patrick Garidel, Alexander B Kuhn, Lars V Schäfer, et al.
Molecular Pharmaceutics|January 24, 2022
Dipolar Interactions and Protein Hydration in Highly Concentrated Antibody FormulationsJosef Hartl, Sergej Friesen, Diethelm Johannsmann, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 17, 2024
Comprehensive analysis and characterization of glycan pairing in therapeutic antibodies and Fc-containing biotherapeutics: Addressing current limitations and implications for N-glycan impactMaximilian Meudt, Julia Baumeister, Boris Mizaikoff, et al.
Journal of Molecular Biology|October 9, 2012
One target-two different binding modes: structural insights into gevokizumab and canakinumab interactions to interleukin-1βMichaela Blech, Daniel Peter, Peter Fischer, et al.
Pageof 4